Polysaccharide Antibody Response Study

NCT02429531 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Specific Polysaccharide Antibody Deficiency

Interventions

BIOLOGICAL: Pneumovax 23 (Sanofi Pasteur MSD)
BIOLOGICAL: Typhim Vi (Sanofi Pasteur MSD)

Sponsor

Universitaire Ziekenhuizen KU Leuven

Collaborators

[object Object]